Nanobiotix to Attend Four Investor Conferences in March
Nanobiotix announces its participation in multiple investor conferences scheduled for March in the United States. The French biotechnology company will present its operations in Boston and Miami to professionals from the financial and healthcare sectors.
Conference Schedule and Details
Nanobiotix will participate in four investor conferences between March 4 and March 11, 2026. The first, TD Cowen's Health Care Conference, will be held on Wednesday, March 4 in Boston, Massachusetts, featuring a 'fireside-chat' format presentation at 5:10 PM CET. Three additional conferences will take place in Miami Beach, Florida: the UBS Biotech Summit on Monday, March 9, the Jefferies Biotech on the Beach Summit on Tuesday, March 10, and the Leerink's Global Healthcare Conference on Wednesday, March 11, with a 'fireside-chat' presentation at 7:20 PM CET.
Representation and Innovation Presentation
Laurent Levy, co-founder of Nanobiotix and Chairman of the Executive Board, along with Bart van Rhijn, CFO and Director of Business Development, will represent the company at these conferences. Nanobiotix will showcase its innovative therapeutic approaches based on physics, developed from three nanotechnology platforms with applications in oncology, bioavailability and biodistribution, as well as disorders of the central nervous system.
